ACUTE KIDNEY INJURY AFTER CD19-TARGETED CAR T CELL THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Myers, Regina [1 ]
Fitzgerald, Julie [1 ]
Elgarten, Caitlin [1 ]
Getz, Kelly [1 ]
Li, Yimei [1 ]
Hogan, Jonathan [1 ]
DiNofia, Amanda [1 ]
Burrows, Evanette [1 ]
Fisher, Brian [1 ]
Aplenc, Richard [1 ]
Grupp, Stephen [1 ]
Laskin, Benjamin [1 ]
Maude, Shannon [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (06) : 1347 - 1356
  • [2] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
    Maude, Shannon L.
    Teachey, David T.
    Porter, David L.
    Grupp, Stephan A.
    BLOOD, 2015, 125 (26) : 4017 - 4023
  • [3] CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL).
    Newman, Haley
    Leahy, Allison Emily Barz
    Li, Yimei
    Liu, Hongyan
    Myers, Regina M.
    DiNofia, Amanda M.
    Dolan, Joseph Gregory
    Callahan, Colleen
    Devine, Kaitlin J.
    Wray, Lisa
    June, Carl H.
    Grupp, Stephan A.
    Rheingold, Susan R.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Davila, Marco L.
    Brentjens, Renier J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (10) : 802 - 808
  • [5] Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
    Geyer, Mark B.
    Manjunath, Shwetha H.
    Evans, Andrew G.
    Park, Jae H.
    Davila, Marco L.
    Cutler, Corey S.
    Wang, Xiuyan
    Wang, Yongzeng
    Senechal, Brigitte
    Riviere, Isabelle
    Sadelain, Michel
    Liesveld, Jane L.
    Brentjens, Renier J.
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1717 - 1721
  • [6] A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia
    DasGupta, Ryan K.
    Marini, Bernard L.
    Rudoni, Joslyn
    Perissinotti, Anthony J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (06) : 453 - 467
  • [7] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
    Wang, Shiyuan
    Wang, Xue
    Ye, Chunying
    Cheng, Hai
    Shi, Ming
    Chen, Wei
    Qi, Kunming
    Wang, Gang
    Wu, Qingyun
    Zeng, Lingyu
    Li, Zhenyu
    Jing, Guangjun
    Zheng, Junnian
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
  • [8] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
    Maude, Shannon L.
    Hucks, George E.
    Self, Alix Eden
    Talekar, Mala Kiran
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Gupta, Minna
    Frey, Noelle V.
    Porter, David L.
    Levine, Bruce L.
    Melenhorst, Jan J.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia (vol 125, pg 4017, 2015)
    Maude, S. L.
    Teachey, D. T.
    Porter, D. L.
    Grupp, S. A.
    BLOOD, 2016, 128 (10) : 1441 - 1441
  • [10] Potent anti-leukemia activities of humanized CD19-targeted CAR-T cells in patients with relapsed/refractory acute lymphoblastic leukemia
    Cao, J.
    Wang, G.
    Zheng, J.
    Xu, K.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1719 - 1720
12345